GlobeStar Therapeutics Corporation
GSTC · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,949 | -$1,488 | -$9,802 | -$542 |
| Dep. & Amort. | $0 | $55 | $1 | $1 |
| Deferred Tax | -$33 | $0 | $2 | $38 |
| Stock-Based Comp. | $1,270 | $509 | $8,131 | $36 |
| Change in WC | $447 | $445 | $221 | $2 |
| Other Non-Cash | $60 | $152 | $695 | $225 |
| Operating Cash Flow | -$206 | -$327 | -$751 | -$240 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $55 | $0 | $95 | $222 |
| Stock Issued | $73 | $5 | $500 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $72 | $322 | $81 | $0 |
| Financing Cash Flow | $199 | $327 | $676 | $223 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | $0 | -$75 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6 | $6 | $81 | $100 |
| End Cash | $0 | $6 | $6 | $81 |
| Free Cash Flow | -$206 | -$327 | -$751 | -$242 |